(Q53145195)

11 May 2018

title

Genetic epidemiology of BRCA1 mutations in Norway. (English)

1 reference

11 May 2018

1 reference

2

1 reference

11 May 2018

Eivind Hovig

6

1 reference

11 May 2018

author name string

P Møller

1

1 reference

11 May 2018

J Apold

3

1 reference

11 May 2018

A Fredriksen

4

1 reference

11 May 2018

A Borg

5

1 reference

11 May 2018

A Hagen

7

1 reference

11 May 2018

B Hagen

8

1 reference

11 May 2018

J C Pedersen

9

1 reference

11 May 2018

L Maehle

10

1 reference

11 May 2018

Norwegian Inherited Breast Cancer Group

11

1 reference

11 May 2018

Norwegian Inherited Ovarian Cancer Group

12

1 reference

11 May 2018

publication date

1 December 2001

1 reference

11 May 2018

European Journal of Cancer

published in

1 reference

11 May 2018

volume

37

1 reference

11 May 2018

issue

18

1 reference

11 May 2018

page(s)

2428-2434

1 reference

11 May 2018

Linkage of early-onset familial breast cancer to chromosome 17q21

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Three per cent of Norwegian Ovarian Cancers are caused by BRCA1 1675delA or 1135insA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

Costs and benefits of diagnosing familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900299-4

7 January 2021

10.1016/S0959-8049(01)00299-4

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018